Greenland Mines Ltd (NASDAQ: GRML) announced that IP Australia has granted Australian Patent No. 2023252508, which covers gene therapy technology exclusively licensed by the company's Biotech Division for the treatment of neuromuscular diseases through expression of the human Klotho protein. The patent strengthens the intellectual property supporting Greenland Mines' Klotho-based therapeutic platform and includes claims covering gene therapy constructs, neuronal and induced pluripotent stem cells, and viral and non-viral delivery systems.
The company said the patent further supports development of its KLTO-202 program targeting amyotrophic lateral sclerosis (“ALS”) and other neuromuscular disorders. This patent grant is a significant milestone for Greenland Mines as it expands the geographical protection of its Klotho gene therapy platform, which is central to the company's biotech strategy. The granted claims are broad, covering key components of the therapeutic approach, and provide a competitive advantage in the development of treatments for devastating neuromuscular conditions.
Greenland Mines Ltd is a Nasdaq-listed company with two operating divisions: Mining and Biotech. The Mining division focuses on the exploration and development of the Skaergaard Project in southeast Greenland and, subject to closing of the previously announced transaction, the Sarfartoq neodymium-praseodymium (Nd-Pr) rare earths project in southwest Greenland. The Biotech division is advancing the Klotho-based KLTO‑202 program with its primary indication for ALS. The company's strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its broader North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
The intellectual property protection provided by this Australian patent is expected to enhance the value of Greenland Mines' biotech assets and support potential partnerships or licensing opportunities. For more details on the patent announcement, the full press release is available at https://nnw.fm/PVbbH. The latest news and updates relating to GRML are available in the company's newsroom at https://nnw.fm/GRML.
